Skip to content

Drug interactions

Cobicistat + Netupitant-palonosetron

Severity: Minor

Cobicistat and Netupitant-palonosetron: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Cobicistat strongly inhibits CYP3A4 and may increase netupitant concentrations. The labeling for netupitant/palonosetron does not require adjustment with CYP3A4 inhibitors, and the clinical effect is generally modest.

What this interaction means in plain words

Cobicistat and Netupitant-palonosetron have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Cobicistat belongs to Miscellaneous; Netupitant-palonosetron belongs to Gastrointestinal Tract.

Evidence level: Moderate

Why it happens

Cobicistat inhibits CYP3A4, reducing the metabolism of netupitant.

What to do

No dose adjustment is needed. Be aware of possible increased netupitant-related adverse effects such as headache and constipation.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Cobicistat and Netupitant-palonosetron, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Cobicistat with Netupitant-palonosetron?

MediHelp rates the interaction as minor. Cobicistat and Netupitant-palonosetron have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Cobicistat strongly inhibits CYP3A4 and may increase netupitant concentrations. The labeling for netupitant/palonosetron does not require adjustment with CYP3A4 inhibitors, and the clinical effect is generally modest.

How serious is the interaction between Cobicistat and Netupitant-palonosetron?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is needed. Be aware of possible increased netupitant-related adverse effects such as headache and constipation.

What other medicines interact with Netupitant-palonosetron?

MediHelp also lists interactions of Netupitant-palonosetron with, for example, Apomorphine, Flibanserin, Apalutamide. The full list is on the Netupitant-palonosetron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in